Navigation Links
Publication in peer-reviewed journal highlights RESPeRATE as effective hypertension treatment
Date:4/22/2009

New York, N.Y.April 22, 2009InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced that RESPeRATEthe only medical device cleared by the FDA and CE-approved for the adjunctive treatment of hypertensionis highlighted as an effective treatment for high blood pressure in the April issue of the Journal of the American Academy of Nurse Practitioners.

The article, written by Elayne DeSimone, ANP, PhD, encourages the entire clinical community, in particular nurse practitioners and physician assistants, to provide individual attention and discuss non-traditional methods when treating patients who suffer from hypertension.

"A patient needs to fully understand his or her individual degree of risk, as well as the consequences of remaining untreated, to feel motivated to take an active part in their healthcare and be compliant with treatment," says DeSimone. "Seven out of 10 patients are not able to achieve their lower blood pressure goals with medication alone, and it is critically important to inform patients of both drug and non-drug treatment options to effectively treat both hypertension and its potential co-morbidities."

In the article, DeSimone highlights the impact of the nurse practitioner as an important source of information and empowerment for the patient. Early detection, monitoring and treatment of hypertension can dramatically reduce the number of hypertensive Americans and have a substantial impact on its associated consequences, both clinically and economically. Promotion of patient awareness and communication, coupled with a blend of drug and non-drug therapies can maximize the effect of a blood pressure treatment regimen.

Diet, exercise and adjunctive treatments are discussed as a way to help patients develop a new routine that fits into their lifestyles and improve treatment compliance. RESPeRATE is highlighted by DeSimone as a treatment that has been proven in multiple clinical studies to produce a significant and lasting decrease in blood pressure, averaging a reduction of 14 points systolic and 8 points diastolic.

"This most recent acknowledgement of RESPeRATE as an effective treatment option for hypertension adds to a growing body of support within the clinical community," says Erez Gavish, president and CEO, InterCure. "Nurse practitioners are vital in providing the best care possible to patients and we hope that these essential caretakers will choose to educate patients about the importance of non-drug therapies such as RESPeRATE."


'/>"/>

Contact: Lisa Mokaba
intercure@schwartz-pr.com
781-684-0770
Schwartz Communications
Source:Eurekalert

Related medicine news :

1. Open access to health research publications
2. Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel
3. Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
4. Scientific Publications Strategy & Delivery Shifts from Marketing to Medical
5. Telemedicine publication expands coverage
6. GSA confers 2007 Richard Kalish Innovative Publication Award to USCs Mather
7. Fry Construction Is Featured in Key Industry Publication
8. CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation
9. Nature publication on pain research
10. Bojan M. Kuure Recognized by Strathmores Whos Who Worldwide Publication
11. Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... , ... After years as an active staff surgeon and having served as ... Wayne Carman transitioned to chief of the Division of Plastic Surgery at what is ... chief and began a second three-year term in January of 2016. , The original ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... gym use and find themselves having to wait longer to access the treadmills. It’s ... their New Year’s resolutions to lose weight and get in shape by joining gyms, ...
(Date:2/5/2016)... Atlanta, Georgia (PRWEB) , ... February 05, 2016 , ... ... pleased to announce their 2nd Annual No Cost Dental Day to individuals in need. ... 4pm. The purpose of this No Cost Dental Day is to provide dental care ...
(Date:2/5/2016)... ... 05, 2016 , ... Health and wellness is a topic that should concern ... they are experiencing an illness. Migraines are a severe form of a headache and ... would not wish the pain on their worst enemy, the feeling can last for ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... –This week, ... the benefits of having a tankless water heater. To view the report, click ... heaters: tank and tankless. While each has their pros and cons, the type chosen ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  As people age, it ... multitude of recommended screenings and tests that are linked ... priority. However, for the majority of aging individuals, hearing ... planning. For the 37.5 million American adults who report ... present to make hearing health a 2016 healthy aging ...
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/jsc97m/global ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, ... their offering. --> http://www.researchandmarkets.com/research/jsc97m/global ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, ... their offering. --> Research ...
(Date:2/5/2016)... --> --> ... the global active pharmaceuticals ingredients (APIs) market stood at ... US$185.9 bn by 2020. It is expected to expand ... The title of the report is "Active Pharmaceutical Ingredients ... by Therapeutic Area) - Global Industry Analysis, Size, Share, ...
Breaking Medicine Technology: